Microparticle-associated tissue factor activity measured with the Zymuphen MP-TF kit and the calibrated automated thrombogram assay

Blood Coagulation and Fibrinolysis

Volumn 23, Issue 6, 2012, Pages 520-526

  Hellum, Marit ^a   Øvstebø, Reidun ^a,b   Trøseid, Anne Marie S ^a   Berg, Jens P ^a,b   Brandtzaeg, Petter ^a,b   Henriksson, Carola E ^a,c  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

functional assay; microparticle; Neisseria meningitides; tissue factor

Indexed keywords

CITRIC ACID; MICROPARTICLE ASSOCIATED TISSUE FACTOR; PHOSPHATIDYLSERINE; THROMBOPLASTIN; UNCLASSIFIED DRUG;

ARTICLE; ASSAY; CALIBRATED AUTOMATED THROMBOGRAM ASSAY; CENTRIFUGATION; FREEZE THAWING; HUMAN; INTERMETHOD COMPARISON; MICROPARTICLE ASSOCIATED TISSUE FACTOR KIT; MONOCYTE; NEISSERIA MENINGITIDIS; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; THROMBOCYTE FREE PLASMA; THROMBOCYTE POOR PLASMA;

AUTOMATION, LABORATORY; BIOLOGICAL ASSAY; BLOOD COAGULATION; BLOOD PLATELETS; CALIBRATION; CELL-DERIVED MICROPARTICLES; HUMANS; NEISSERIA MENINGITIDIS; REAGENT KITS, DIAGNOSTIC; SPECIMEN HANDLING; THROMBIN; THROMBOPLASTIN; WHOLE BLOOD COAGULATION TIME;

EID: 84865505020     PISSN: 09575235     EISSN: 14735733     Source Type: Journal    
DOI: 10.1097/MBC.0b013e328354a256     Document Type: Article

References (39)

1. Nieuwland R, Berckmans RJ, McGregor S, Boing AN, Romijn FP, Westendorp RG, et al. Cellular origin and procoagulant properties of microparticles in meningococcal sepsis. Blood 2000; 95:930-935. (Pubitemid 30063043)
2. Bogdanov VY, Osterud B. Cardiovascular complications of diabetes mellitus: the tissue factor perspective. Thromb Res 2010; 125:112-118.
3. Mallat Z, Hugel B, Ohan J, Leseche G, Freyssinet JM, Tedgui A. Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosis in plaque thrombogenicity. Circulation 1999; 99:348-353. (Pubitemid 29051259)
4. Morel O, Toti F, Hugel B, Bakouboula B, Camoin-Jau L, Dignat-George F, et al. Procoagulant microparticles: disrupting the vascular homeostasis equation? Arterioscler Thromb Vasc Biol 2006; 26:2594-2604.
5. Freyssinet JM. Cellular microparticles: what are they bad or good for? J Thromb Haemost 2003; 1:1655-1662.
6. Owens AP III, Mackman N. Microparticles in hemostasis and thrombosis. Circ Res 2011; 108:1284-1297.
7. Davizon P, Munday AD, Lopez JA. Tissue factor, lipid rafts, and microparticles. Semin Thromb Hemost 2010; 36:857-864.
8. Morel O, Jesel L, Freyssinet JM, Toti F. Cellular mechanisms underlying the formation of circulating microparticles. Arterioscler Thromb Vasc Biol 2011; 31:15-26.
9. Vandendries ER, Furie BC, Furie B. Role of P-selectin and PSGL-1 in coagulation and thrombosis. Thromb Haemost 2004; 92:459-466. (Pubitemid 39248002)
10. del Conde I, Shrimpton CN, Thiagarajan P, Lopez JA. Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. Blood 2005; 106:1604-1611. (Pubitemid 41208572)
11. Aras O, Shet A, Bach RR, Hysjulien JL, Slungaard A, Hebbel RP, et al. Induction of microparticle- and cell-associated intravascular tissue factor in human endotoxemia. Blood 2004; 103:4545-4553. (Pubitemid 38745982)
12. Bakouboula B, Morel O, Faure A, Zobairi F, Jesel L, Trinh A, et al. Procoagulant membrane microparticles correlate with the severity of pulmonary arterial hypertension. Am J Respir Crit Care Med 2008; 177:536-543. (Pubitemid 351442193)
13. Tesselaar ME, Romijn FP, van der Linden IK, Prins FA, Bertina RM, Osanto S. Microparticle-associated tissue factor activity: a link between cancer and thrombosis? J Thromb Haemost 2007; 5:520-527. (Pubitemid 46680685)
14. Lechner D, Weltermann A. Circulating tissue factor-exposing microparticles. Thromb Res 2008; 122 (Suppl 1):S47-S54.
15. Piccin A, Murphy WG, Smith OP. Circulating microparticles: pathophysiology and clinical implications. Blood Rev 2007; 21:157-171. (Pubitemid 46529055)
16. Butenas S, Orfeo T,Mann KG. Tissue factor in coagulation: which? where? when? Arterioscler Thromb Vasc Biol 2009; 29:1989-1996.
17. Key NS, Mackman N. Tissue factor and its measurement in whole blood, plasma, and microparticles. Semin Thromb Hemost 2010; 36:865-875.
18. Yuana Y, Bertina RM, Osanto S. Preanalytical and analytical issues in the analysis of blood microparticles. Thromb Haemost 2011; 105:396-408.
19. Kasthuri RS, Glover SL, Boles J, Mackman N. Tissue factor and tissue factor pathway inhibitor as key regulators of global hemostasis: measurement of their levels in coagulation assays. Semin Thromb Hemost 2010; 36:764-771.
20. Aass HC, Ovstebo R, Troseid AM, Kierulf P, Berg JP, Henriksson CE. Fluorescent particles in the antibody solution result in false TF- and CD14-positive microparticles in flow cytometric analysis. Cytometry A 2011; 79:990-999.
21. Hemker HC, Giesen P, Al Dieri R, Regnault V, deSmedt E, Wagenvoord R, et al. Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiol Haemost Thromb 2003; 33:4-15. (Pubitemid 37449290)
22. Bidot L, Jy W, Bidot C Jr, Jimenez JJ, Fontana V, Horstman LL, et al. Microparticle-mediated thrombin generation assay: increased activity in patients with recurrent thrombosis. J Thromb Haemost 2008; 6:913-919. (Pubitemid 351689911)
23. Ollivier V, Wang J, Manly D, Machlus KR, Wolberg AS, Jandrot-Perrus M, et al. Detection of endogenous tissue factor levels in plasma using the calibrated automated thrombogram assay. Thromb Res 2010; 125:90-96.
24. Haubold K, Rink M, Spath B, Friedrich M, Chun FK, Marx G, et al. Tissue factor procoagulant activity of plasma microparticles is increased in patients with early-stage prostate cancer. Thromb Haemost 2009; 101:1147-1155.
25. Trappenburg MC, van Schilfgaarde M, Bredewold EO, van Aalderen MC, Spronk HM, ten Cate H, et al. Elevated numbers and altered subsets of procoagulant microparticles in breast cancer patients using endocrine therapy. Thromb Res 2011; 127:363-369.
26. Aleman MM, Gardiner C, Harrison P, Wolberg AS. Differential contributions of monocyte- and platelet-derived microparticles towards thrombin generation and fibrin formation and stability. J Thromb Haemost 2011; 9:2251-2261.
27. Debaugnies F, Azerad MA, Noubouossie D, Rozen L, Hemker HC, Corazza F, et al. Evaluation of the procoagulant activity in the plasma of cancer patients using a thrombin generation assay. Thromb Res 2010; 126:531-535.
28. Bogdanov VY, Cimmino G, Tardos JG, Tunstead JR, Badimon JJ. Assessment of plasma tissue factor activity in patients presenting with coronary artery disease: limitations of a commercial assay. J Thromb Haemost 2009; 7:894-897.
29. Ovstebo R, Dalsbotten Aass HC, Haug KB, Siebke Troseid AM, Gopinathan U, Kierulf P, et al. LPS from Neisseria meningitidis is crucial for inducing monocyte- and microparticle-associated tissue factor activity but not for tissue factor expression. Innate Immun 2011 DOI: 10.1177/1753425911428230 (in press).
30. Holten E. Serotypes of Neisseria meningitidis isolated from patients in Norway during the first six months of. J Clin Microbiol 1979; 9:186-188. (Pubitemid 9123780)
31. Ovstebo R, Brandtzaeg P, Brusletto B, Haug KB, Lande K, Hoiby EA, et al. Use of robotized DNA isolation and real-time PCR to quantify and identify close correlation between levels of Neisseria meningitidis DNA and lipopolysaccharides in plasma and cerebrospinal fluid from patients with systemic meningococcal disease. J Clin Microbiol 2004; 42:2980-2987. (Pubitemid 38938046)
32. Wolberg AS, Kon RH, Monroe DM, Ezban M, Roberts HR, Hoffman M. Deencryption of cellular tissue factor is independent of its cytoplasmic domain. Biochem Biophys Res Commun 2000; 272:332-336. (Pubitemid 30444618)
33. Bach RR. Tissue factor encryption. Arterioscler Thromb Vasc Biol 2006; 26:456-461.
34. Lee RD, Barcel DA, Williams JC, Wang JG, Boles JC, Manly DA, et al. Preanalytical and analytical variables affecting the measurement of plasmaderived microparticle tissue factor activity. Thromb Res 2012; 129:80-85.
35. Hackett SJ, Guiver M, Marsh J, Sills JA, Thomson AP, Kaczmarski EB, et al. Meningococcal bacterial DNA load at presentation correlates with disease severity. Arch Dis Child 2002; 86:44-46. (Pubitemid 36307629)
36. Johnson GJ, Leis LA, Bach RR. Tissue factor activity of blood mononuclear cells is increased after total knee arthroplasty. Thromb Haemost 2009; 102:728-734.
37. Luddington R, Baglin T. Clinical measurement of thrombin generation by calibrated automated thrombography requires contact factor inhibition. J Thromb Haemost 2004; 2:1954-1959. (Pubitemid 40192749)
38. Spronk HM, Dielis AW, Panova-Noeva M, van Oerle R, Govers-Riemslag JW, Hamulyak K, et al. Monitoring thrombin generation: is addition of corn trypsin inhibitor needed? Thromb Haemost 2009; 101:1156-1162.
39. Jy W, Horstman LL, Jimenez JJ, Ahn YS, Biro E, Nieuwland R, et al. Measuring circulating cell-derived microparticles. J Thromb Haemost 2004; 2:1842-1851. (Pubitemid 40197488)